[1]
|
L. Norgren, W. R. Hiatt, J. A. Dormandy, M. R. Nehler, K. A. Harris and F. G. Fowkes and TASC II Working Group, “Intersociety Consensus for the Management of Peripheral Arterial Disease (TASC II),” European Journal of Vascular and Endovascular Surgery, Vol. 33, Supplement 1, 2007, pp. S1-S75.
doi:10.1016/j.ejvs.2006.09.024
|
[2]
|
L. Prompers, N. Schaper, J. Apelqvist, M. Edmonds, E. Jude and D. Mauricio, “Prediction of Outcome in Individuals with Diabetic Foot Ulcers: Focus on the Differences between Individuals with and without Peripheral Arterial Disease. The EURODIALE Study,” Diabetologia, Vol. 51, No. 5, 2008, pp. 747-755.
doi:10.1007/s00125-008-0940-0
|
[3]
|
M. A. Gershater, M. Londahl, P. Nyberg, J. Larsson, J. Thorne and M. Eneroth, “Complexity of Factors Related to Outcome of Neuropathic and Neuroischaemic/Ischaemic Diabetic Foot Ulcers: A Cohort Study,” Diabetologia, Vol. 52, No. 3, 2009, pp. 398-407.
doi:10.1007/s00125-008-1226-2
|
[4]
|
F. L. Game, S. Y. Chipchase, R. Hubbard, R. P. Burden and W. J. Jeffcoate, “Temporal Association between the Incidence of Foot Ulceration and the Start of Dialysis in Diabetes Mellitus,” Nephrology Dialysis Transplantation, Vol. 21, No. 11, 2006, pp. 3207-3210.
doi:10.1093/ndt/gfl427
|
[5]
|
M. Albers, M. Romiti, C. A. Braganca Pereira, R. L. A. Fonseca and M. Da Silva Junior, “A Metaanalysis of Infrainguinal Arterial Reconstruction in Patients with ESRD,” European Journal of Vascular and Endovascular Surgery, Vol. 22, No. 4, 2001, pp. 294-300.
doi:10.1053/ejvs.2001.1469
|
[6]
|
F. Pomposelli, “Arterial Imaging in Patients with Lower Extremity Ischemia and Diabetes Mellitus,” Journal of Vascular Surgery, Vol. 52, Supplement 3, 2010, pp. 81S-91S. doi:10.1016/j.jvs.2010.06.013
|
[7]
|
M. Heikkinen, M. Salmenpera, A. Lepantalo and M. Lepantalo, “Diabetes Care for Patients with Peripheral Arterial Disease,” European Journal of Vascular and Endovascular Surgery, Vol. 33, No. 5, 2007, pp. 583-591.
doi:10.1016/j.ejvs.2007.01.012
|
[8]
|
M. R. Prince, H. Zhang, M. Morris, J. L. MacGregor, M. E. Grossman and J. Silberzweig, “Incidence of Nephrogenic Systemic Fibrosis at Two Largemedical Centers,” Radiology, Vol. 248, No. 3, 2008, pp. 807-816.
doi:10.1148/radiol.2483071863
|
[9]
|
C. Rydahl, H. S. Thomsen and P. Marckmann, “High Prevalence of Nephrogenic Systemic Fibrosis in Chronic Renal Failure Patients Exposed to Gadodiamide, a Gadolinium-Containing Magnetic Resonance Contrast Agent,” Investigative Radiology, Vol. 43, No. 2, 2008, pp. 141-144.
|
[10]
|
R. Wertman, E. Altun, D. R. Martin, D. G. Mitchell, J. R. Leyendecker and R. B. O’Malley, “Risk of Nephrogenic Systemic Fibrosis: Evaluation of Gadolinium Chelate Contrast Agents at Four American Universities,” Radiology, Vol. 248, No. 3, 2008, pp. 799-806.
doi:10.1148/radiol.2483072093
|
[11]
|
R. J. Hinchliffe, G. Andros, J. Apelqvist, K. Bakker, S. Friederichs and J. Lammer, “A Systematic Review of the Effectiveness of Revascularization of the Ulcerated Foot in Patients with Diabetes and Peripheral Arterial Disease,” Diabetes/Metabolism Research and Reviews, Vol. 28, Supplement 1, 2012, pp. 179-217.
doi:10.1002/dmrr.2249
|
[12]
|
C. D. Owens, K. J. Ho, S. Kim, A. Schanzer, J. Lin and E. Matros, “Refinement of Survival Prediction in Patients Undergoing Lower Extremity Bypass Surgery: Stratification by Chronic Kidney Disease Classification,” Journal of Vascular Surgery, Vol. 45, No. 5, 2007, pp. 944-952.
doi:10.1016/j.jvs.2007.01.025
|
[13]
|
S. Rajagopalan, S. Dellegrottaglie, A. L. Furniss, B. W. Gillespie, S. Satayathum and N. Lameire, “Peripheral Arterial Disease in Patients with End-Stage Renal Disease: Observation from the Dialysis Outcomes and Practice Patterns Study (DOPPS),” Circulation, Vol. 114, No. 18, 2006, pp. 1914-1922.
doi:10.1161/CIRCULATIONAHA.105.607390
|
[14]
|
S. Fishbane, S. Youn, E. Flaster, G. Adam and J. K. Maesaka, “Ankle-Arm Blood Pressure Index as a Predictor of Mortality in Hemodialysis Patients,” American Journal of Kidney Diseases, Vol. 27, No. 5, 1996, pp. 668-672. doi:10.1016/S0272-6386(96)90101-8
|
[15]
|
A. O’Hare and K. Johansen, “Lower-Extremity Peripheral Arterial Disease among Patients with End-Stage Renal Disease,” Journal of the American Society of Nephrology, Vol. 12, No. 12, 2001, pp. 2838-2847.
|
[16]
|
A. O’Hare, D. V. Glidden, C. S. Fox and C. Hsu, “High Prevalence of Peripheral Arterial Disease in Person with Renal Insufficiency. Results from the National Health and Nutritional Examination Survey. 1999-2000,” Circulation, Vol. 109, No. 3, 2004, pp. 320-323.
doi:10.1161/01.CIR.0000114519.75433.DD
|
[17]
|
K. Wattanakit, A. R. Folsom, E. Selvin, J. Coresh, A. T. Hirsch and B. D. Weatherley, “Kidney Function and Risk of Peripheral Arterial Disease: Results from the Atherosclerosis Risk in Communities (ARIC) Study,” Journal of the American Society of Nephrology, Vol. 18, No. 2, 2007, pp. 629-636. doi:10.1681/ASN.2005111204
|
[18]
|
B. G. Jaar, L. C. Plantinga, B. C. Astor, N. E. Fink, C. Longenecker and R. P. Tracy, “Novel and Traditional Cardiovascular Risk Factors for Peripheral Arterial Disease in Incident-Dyalisis Patients,” Advances in Chronic Kidney Disease, Vol. 14, No. 3, 2007, pp. 304-313.
doi:10.1053/j.ackd.2007.04.005
|
[19]
|
R. N. Foley, P. S. Parfrey, J. D. Harnett, G. M. Kent, L. Hu and R. O’Dea, “Hypocalcemia, Morbidity, and Mortality in End-Stage Renal Disease,” American Journal of Nephrology, Vol. 16, No. 5, 1996, pp. 386-393.
doi:10.1159/000169030
|
[20]
|
B. F. Culleton, M. G. Larson, P. W. F. Wilson, J. C. Evans, P. S. Parfrey and D. Levy “Cardiovascular Disease and Mortality in a Community-Based Cohort with Mild Renal Insufficiency,” Kidney International, Vol. 56, No. 6, 1999, pp. 2214-2219.
doi:10.1046/j.1523-1755.1999.00773.x
|
[21]
|
A. S. Go, G. M. Chertow, D. Fan, C. E. McCullock and C. Y. Hsu, “Chronic Kidney Disease and the Risk of Death, Cardiovascular Events, and Hospitalization,” The New England Journal of Medicine, Vol. 351, No. 13, 2004, pp. 1296-1305. doi:10.1056/NEJMoa041031
|
[22]
|
M. Venermo, F. Biancari, E. Arvela, M. Korhonen, M. Soderstrom and K. Halmesmaki, “The Role of Chronic Kidney Disease as a Predictor of Outcome after Revascularisation of the Ulcerated Diabetic Foot,” Diabetologia, Vol. 54, No. 12, 2011, pp. 2971-2977.
doi:10.1007/s00125-011-2279-1
|